Photocure ASA - Proxy Solicitation & Information Statement 2026

Photocure ASA - Notice of the Annual General Meeting 26 June 2026

Oslo, Norway, 5 June 2026: Photocure ASA (OSE: PHO), calls for the annual

general meeting of Photocure ASA to be held on 26 June 2026 at 17:00 hours

(CEST), virtual through the general meeting portal administered by Euronext

Securities Oslo (the "Euronext Securities Portal").

The general meeting will be webcasted live and a link will be available on the

company's website in due time in advance of the general meeting. It will not be

possible to attend in person. Shareholders may also vote in advance or submit a

proxy with voting instructions.

The notice convening the general meeting, including the agenda and the board's

proposals to the matters to be dealt with, is enclosed with this notification

and will be sent to all shareholders with known addresses.

Relevant documents referred to in the notice are made available on

www.photocure.com.

For further information, please contact:

Priyam Shah

Vice President Investor Relations

Tel: +17176815072

About Photocure ASA

Photocure: The Bladder Cancer Company delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, making

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us at

www.photocure.com/news

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

AI assistant